Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Profit After Tax (2019 - 2023)

Historic Profit After Tax for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$46.7 million.

  • ADC Therapeutics' Profit After Tax rose 767.07% to -$46.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$146.3 million, marking a year-over-year decrease of 1941.49%. This contributed to the annual value of $4.7 billion for FY2022, which is 527.6% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Profit After Tax is -$46.7 million, which was up 767.07% from -$48.9 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Profit After Tax peaked at $4.7 billion during Q1 2022, and registered a low of -$126.6 million during Q2 2020.
  • In the last 5 years, ADC Therapeutics' Profit After Tax had a median value of -$34381.0 in 2021 and averaged $717.7 million.
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Profit After Tax showed a top increase of 16397141235.86% in 2022 and a maximum decrease of 112197984.93% in 2022.
  • Over the past 5 years, ADC Therapeutics' Profit After Tax (Quarter) stood at -$35285.0 in 2019, then tumbled by 57510.88% to -$20.3 million in 2020, then surged by 99.83% to -$34381.0 in 2021, then grew by 29.74% to -$24157.0 in 2022, then tumbled by 193326.34% to -$46.7 million in 2023.
  • Its Profit After Tax was -$46.7 million in Q3 2023, compared to -$48.9 million in Q2 2023 and $3.9 billion in Q1 2023.